Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Futurewave Acquisition Corp (FWAC)

Futurewave Acquisition Corp. lets unit holders split units into shares, rights and warrants

Neutral Impact 2 of 5 shareholder Written later

Futurewave Acquisition Corporation, a blank check company, said holders of its units may separately trade the ordinary shares, rights and warrants included in the units starting on or about July 31, 2026. Units not separated will keep trading under FWACU, and the separated securities are expected to trade under FWAC, FWACR and FWACW. The change is administrative and does not alter the securities' terms or the company's business.

Key points

  • Separate trading of ordinary shares, rights and warrants expected to begin on or about July 31, 2026
  • Separated securities expected to trade as FWAC (shares), FWACR (rights) and FWACW (warrants) on Nasdaq Capital Market
  • Each whole warrant entitles the holder to buy one ordinary share at $11.50; holders must work through their brokers with Continental Stock Transfer & Trust Company to separate units

The filing

CompanyFuturewave Acquisition Corp (FWAC)
Form8-K, current report
Filed with the SECJul 30, 2026, 6:01 AM ET
Accession number0001829126-26-008061

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:48 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 30, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.